Swiss Healthcare Startups’ Post

Join us for a day of celebrating #innovation and #entrepreneurship with founders, investors, and industry experts. Highlights include interviews and discussions on therapeutics, neurotech, and early cancer detection!

Deadline March 13!! To sign up for a 1-on-1 meeting with National Cancer Institute (NCI) #SBIR experts to discuss your project & how to make your application for funding more competitive, click this link: https://bit.ly/4bS0Nfr Mar 20, at Portal Innovations, LLC #SBIR experts will disucc new funding opportunities available for #Chicagobiotech #academic #innovators. Join us to have your questions answered. Topics include *SBIR/STTR eligibility requirements *NIH SBIR/STTR process and new cancer-focused funding opportunities from NCI *NCI SBIR/STTR initiatives such as the I-Corps at NIH Entrepreneurship Program, Applicant Assistant Program, etc. *Practical strategies on how to successfully submit competitive research proposals #CancerResearch #ResearchFunding #Startup #StartupFunding #AcademicInnovators

KOREAN STARTUP NEWS. Life Science startups in Korea are bustling. Here's the most recent news from promising Korean life science startups: • ArtBlood, specializing in blood production for transfusion, secured a $4.8 million series A funding. • Lunit AI's study demonstrates that using Lunit INSIGHT MMG, their AI image analysis solution for mammography, can increase the likelihood of early breast cancer diagnosis. • Curocell received government funding to develop an advanced CAR-T therapy for lupus treatment. • Watson & Company's mental wellness device, Pocus, gained recognition for its effectiveness at the 2022 Hangzhou Asian Games, helping with stress management and improving sleep quality using neuromodulation. For more information on Korea's Life Science startups, read the news below! Source: KED Global, Korea Biomedical Review #KICWashingtonDC #KoreaInnovationCenter #KICDC #KoreanStartup #Startup #LifeScience #Bio #Pharma

📰 New article on our #blog! Two weeks ago we published an article on Dry AMD explaining a patient's journey. Now is the time to delve deeper into the experience of living with Wet AMD. Take a look at the article: https://lnkd.in/eXgvjCpf Keep an eye open for more. 😉 #InvestInMantisPhotonics #TheEyeIsTheWindowToYourHealth #Startup #HyperspectralCamera #EarlyDiagnosisRevolution #OphthalmologicDisease #NeurologicalDisorders #AMD

📢📢📢📢 One Biosciences featured in the "Top 100 Startups to Invest in" ranking by Challenges magazine !   This recognition follows some impressive achievements since our inception in 2020. Here are some: -A clear technological and scientific edge established for our discovery engine (multi-modal data fueling our proprietary AI models for a clear purpose and vision) -Several discovery programs underway in oncology and beyond, in partnership with leading academic centers such as Institut Curie and Institut Gustave Roussy -A unique partnership with Greater Paris University Hospitals - AP-HP to discover new targets in a rare kidney disease -Our first targets reaching validation stage in high grade ovarian cancer   On another front, we have bolstered our leadership team with: -The appointment of a great leader, Hedi Ben Brahim, as CEO in September 2023 with a mission to aggressively scale-up the company. -The appointments of two industry leaders, Dr Scott Braunstein and Dr. Vincent Miller to our Board of Directors in March 2024.   This follows our laureate position in the « 100 Leading teams whose discovery will change lives » by Le Point Magazine last year !   A heartfelt thank you to Challenges magazine for this honor and to our partners, our co-founder Home Biosciences and very importantly to our fantastic team.   Onward and upward for patients suffering from rare diseases and hard-to-treat cancers.      #ChallengesTop100 #Biotech #Innovation #HealthcareRevolution #AI #startups

An increasingly ageing global population means that diseases like dementia, Alzheimer’s and motor neuron disease are on the rise. Alzheimer’s Disease International predicts that 78m people globally will suffer from dementia by 2030, up from 55m in 2020. After 20 years of no new treatments, two new drugs for Alzheimer’s emerged in 2023 — and investors tell me that it's shifted VC attention towards startups in the neurodegenerative disease sector, with funding going into everything from novel drugs to methods to make treating the brain easier and more effective. “We are seeing more entrepreneurs looking to take really exciting science and look to build companies and spin them out — and that's because the science is maturing in its own right. The deal flow we are privy to just gets better and better, more mature, more insightful and more exciting," said Laurence Barker from the Dementia Discovery Fund (DDF). So, what are startups in the space working on — and why are investors turning to the sector? My latest for Sifted: https://lnkd.in/e4JZPwcw

Granza Bio (YC W24) secures $7M seed funding from Felicis and YC to advance cancer #treatment delivery. Founders Ashwin Menon Nandakumar and Ashwin Jainarayanan met at Oxford while #working on their doctorates and bonded over a shared #interest in oncology. Inspired by groundbreaking research from Professor Michael Dustin, they decided to turn this discovery into a #startup. Initially planning to raise $2.5M, they quickly exceeded their #goal due to high #investor interest, ultimately securing $7.14M. Granza Bio’s innovative "attack particles" harness the body's immune system to target cancer and autoimmune diseases, promising safer and more effective therapies. Felicis, known for its early bets on tech giants, sees immense potential in Granza's novel therapeutic delivery mechanism. #Startups #Entrepreneurship #Innovation #DigitalMarketing #TechTrends  #AI #VentureCapital #Ecommerce #Leadership #BusinessGrowth If you spot any inaccuracies, please let us know so we can correct them. Your feedback helps us improve. Thanks! 

[#PrixGalienUSA] Since 2022, the Prix Galien Medstartup, which rewarded the most promising French companies in partnership with American firms, has become the Prix Galien Best Startup, opening the prize to all innovative startups worldwide. At Business France, we are proud that innovative French healthcare startup have been recognized, with 1 French winner among the 3 winners in this category over the past 2 years: 2023: Volta Medical with its innovative artificial intelligence solutions that enhance the diagnosis and treatment of cardiac disorders. 2022: Quantum Surgical SAS and its revolutionary technology offer minimally invasive solutions for tumor treatment, utilizing advanced imaging for precise interventions. Not forgetting all the Prix Galien Medstartup winners between 2013 and 2022. Here are some of those who have triumphed in the past: TreeFrog Therapeutics (in partnership with QC-Stem Consortium) - 2020 Wandercraft (in partnership with Shirley Ryan Ability Lab, Caltech, and Amberlabs) - 2020 E-Scopics (in partnership with The Ultrasonic Material Characterization) - 2020 Acticor Biotech (in partnership with Memorial Hermann) - 2021 Hemerion Therapeutics (in partnership with Mount Sinai) - 2021 Vivet Therapeutics (in partnership with Pfizer and Mirum) - 2021   🎉Congratulations to all these companies for their groundbreaking contributions to healthcare through their innovative discoveries and technologies! Roxane Valfort - Jonathan Moreil - Elsa Rive Boukadoum - Ludmilla Potiron - Bruno Cohen - Xinyi CAO - Marie-Astrid Sevilla - Jerome Revole -The Galien Foundation - Business France – Santé 🚀

The fastest growing startup in InterSystems portfolio from the latest Caelestinus batch opens £500K round in UK Praxium AI - is an AI co-pilot for breast cancer diagnosis. The software helps generalist radiologists from low and middle-income countries literally save lives! Nelson Jordan and Nicolas Ivanov are serial founders with impressive track records! So during the Caelestinus program, they have refined communication and GTM strategy and have taken big steps in financial preparations before the investment round. Look at the progress during the program!!! 1️⃣ Onboarded first paid customer 2️⃣ Signed LOI with a medical equipment manufacturer 3️⃣ Set up 2 new pilots 4️⃣ Won InnovateUK awarding £250k and InterSystems $25k USD 5️⃣ Praxium pitch deck was rated as the best one with the biggest improvement 6️⃣ Were nominated for ‘most innovative use of AI’ at the InterSystems Global Summit Thanks to InterSystems experts, who handpick and develop the best-performing startups! 😎 Evgeny Shvarov Tomas Studenik Jan Faflík Vita Tsareva Martin Lahučký Petr Žabka DM Founders for more info and jump in the deal! #healthtech #Intersystems #VC #invest #startup #growth #Venturecapital #medtech

#fundingalert 💼Company: OverT Bio 💰Funding: $16Million  ⚡Round: Seed 👥Investors: Fusion Fund, OMX Ventures, Alexandria Venture Investments, Gaingels, Civilization Ventures, Hawktail, and Cancer Research Institute (CRI), ARTIS Ventures and Wing VC Drs. Mat Legut and Neville Sanjana founded OverT Bio in 2022 with the goal of addressing significant unmet medical needs in solid tumours. The company has created platforms for synthetic biology, single-cell multiomic analysis, and parallel genomic screening that integrate big data analysis techniques with cell engineering technologies. The money will be used by the business to develop discovery platforms that target the main obstacles to cell therapy in an effort to develop long-lasting and effective therapies for advanced solid tumours. Read more - https://lnkd.in/ekjbrtj4 To share your startup story write us on - contact@startuprise.io #OverTBio #syntheticbiology #technologies #business #funding #fundingnews #news #startup #startupnews #startuprise